Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs

ObjectiveWe aimed to evaluate and compare the efficacy and safety of three antidiabetic drug classes—SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas—in patients with type 2 diabetes mellitus (T2DM) complicated by heart failure (HF). We focused on their differential effects on both cardi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Huize Gao, Qian Wei, Anqi Zou, Keying Yu, Da Song, Jian Li, Huize Han, Aidong Liu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-06-01
Saila:	Frontiers in Endocrinology
Gaiak:	type 2 diabetes with heart failure SGLT2 inhibitors GLP-1 receptor agonists efficacy and safety network meta-analysis
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1562815/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!